• Check with publisher
  • Published date: January 15, 2020
    • Shirley, New York, United States

Given the non-ignorable essential and the increasing attention paid to drug hepatotoxicity, fully profiling of DILI potential by predictive in vitro assays can allow optimizing of drug components during the early development stage, which enhances both safety and efficacy. Currently, Creative Biolabs has combined multiple effective in vitro models with high content analysis (HCA) technology, providing a thorough and reliable approach for detecting hepatotoxicity potentials while supplying detailed mechanism information underlying the observed toxicity. https://www.creative-biolabs.com/drug-discovery/therapeutics/hepatotoxicity.htm .

Jerry Carter
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • hERG Screening

    hERG Screening

    Biomedical Sciences Shirley (New York) January 15, 2020 Check with publisher

    Cardiotoxicity is one of the major safety concerns in drug discovery, which is the leading reason for development termination and market withdraw or restriction. Particularly, hERG ion channel inhibition or blockade is responsible for 25-40% of all p...

  • Drug-Drug Interactions

    Drug-Drug Interactions

    Biomedical Sciences Shirley (New York) January 15, 2020 Check with publisher

    As there is increasing population taking multiple medications, adverse drug-drug interactions (DDI) has become a crucial issue. If a certain component of drug A changes the activity of enzymes or transporters involved in the metabolism of drug B, it ...

  • Cardiotoxicity


    Biomedical Sciences Shirley (New York) January 15, 2020 Check with publisher

    Drug-induced cardiotoxicity is the leading cause of both drug development failures and market withdraw or restriction. Compounds that exert cardiovascular toxicity, no matter acute or subtle effect, can lead to severe adverse consequences, such as ar...